Patents by Inventor Christopher McBride

Christopher McBride has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220063217
    Abstract: According to one embodiment, a system for manufacturing a fully impregnated thermoplastic prepreg includes a mechanism for moving a fabric or mat and a drying mechanism that removes residual moisture from at least one surface of the fabric or mat. The system also includes a resin application mechanism that applies a reactive resin to the fabric or mat and a press mechanism that presses the coated fabric or mat to ensure that the resin fully saturates the fabric or mat. The system further includes a curing oven through which the coated fabric or mat is moved to polymerize the resin and thereby form a thermoplastic polymer so that upon exiting the oven, the fabric or mat is fully impregnated with the thermoplastic polymer. During at least a portion of the process, humidity in the vicinity of the coated fabric or mat is maintained at substantially zero.
    Type: Application
    Filed: November 11, 2021
    Publication date: March 3, 2022
    Inventors: Mingfu Zhang, Klaus Friedrich Gleich, Asheber Yohannes, Michael John Block, Jawed Asrar, Derek Cooper Bristol, Christopher P Sandoval, Matthew Walp, Edwing Chapparo-Chavez, Stanislav O Kukatin, Albert Patrick Faulkinbury, Christopher McBride, Bradley Ray Lockwood
  • Publication number: 20210395268
    Abstract: The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1? and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
    Type: Application
    Filed: January 25, 2021
    Publication date: December 23, 2021
    Applicant: Genentech, Inc.
    Inventors: Jeffrey A. STAFFORD, James M. VEAL, Lynnie Lin TRZOSS, Christopher MCBRIDE
  • Publication number: 20210261568
    Abstract: The present disclosure relates to novel sulfonylurea compounds and related compounds useful in treating a disorder responsive to modulation of cytokines such as IL-1? and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
    Type: Application
    Filed: January 15, 2021
    Publication date: August 26, 2021
    Applicant: Genentech, Inc.
    Inventors: Jeffrey A. STAFFORD, James M. VEAL, Lynnie Lin TRZOSS, Christopher MCBRIDE, Richard M. PASTOR, Steven Thomas STABEN, Craig STIVALA, Matthew VOLGRAF
  • Publication number: 20210253596
    Abstract: The present disclosure relates to novel sulfonimidamide compounds and related compounds and their use in treating a disorder responsive to modulation of cytokines such as IL-1? and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
    Type: Application
    Filed: January 15, 2021
    Publication date: August 19, 2021
    Applicant: Genentech, Inc.
    Inventors: Christopher MCBRIDE, Lynnie Lin TRZOSS, Amogh BOLOOR, Nadezda V. SOKOLOVA, Richard M. PASTOR, Steven Thomas STABEN, Craig STIVALA, Matthew VOLGRAF, Sarah M. BRONNER
  • Patent number: 11040985
    Abstract: The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1? and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: June 22, 2021
    Assignee: Genentech, Inc.
    Inventors: Jeffrey A. Stafford, James M. Veal, Lynnie Lin Trzoss, Christopher McBride
  • Publication number: 20210094842
    Abstract: A multi-functional slurry processing system (“VARCOR”) and associated methods is disclosed. The present examples provide a multi-functional slurry processing system incorporating systems and methods for separating liquid and solid components in slurries. In particular the systems and methods described herein produce clean water, dried solids, and potential concentration of desirable constituents with a boiling point lower than water. At least one example of the multi-functional slurry processing system provides a self-contained processing facility configured to efficiently convert high water-content slurries into its constituent solid and liquid fractions and subsequently generating and collecting clean water and concentrating desirable constituents with a boiling point lower than water.
    Type: Application
    Filed: October 12, 2020
    Publication date: April 1, 2021
    Applicant: Sedron Technologies, LLC
    Inventors: Peter William Janicki, Sara Amber Van Tassel, John Edward Weller, Stanley James Janicki, Warren Lewis Heartwood, Keith Boyd Fackler, II, Alex James Gross, Tyler Everett Hamke, Austin George Law, Eric Christopher McBride, Ann Kate Nowinski, Liam Joseph Potocsnak, James O'Keefe Armstrong
  • Patent number: 10954676
    Abstract: A rooftop equipment attachment system includes a rooftop having a roof deck, an insulation layer positioned atop the roof deck, a plurality of metallic roof plates that secure the insulation layer to the roof deck, and a roofing membrane secured atop the insulation layer. The roofing membrane covers the plurality of metallic roof plates. The system includes a frame for supporting rooftop equipment. The frame includes a plurality of mounting supports that are positionable atop the rooftop at positions that are above at least a portion of the plurality of metallic roof plates. The plurality of mounting supports are configured to support the frame and any rooftop equipment mounted thereon. Each of the plurality of mounting supports includes a magnetic element that is configured to secure a particular one of the plurality of mounting supports with a particular one of the plurality of metallic roof plates.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: March 23, 2021
    Assignee: Johns Manville
    Inventors: Christopher McBride, Zebonie Sukle
  • Patent number: 10800667
    Abstract: A multi-functional slurry processing system (“VARCOR”) and associated methods is disclosed. The present examples provide a multi-functional slurry processing system incorporating systems and methods for separating liquid and solid components in slurries. In particular the systems and methods described herein produce clean water, dried solids, and potential concentration of desirable constituents with a boiling point lower than water. At least one example of the multi-functional slurry processing system provides a self-contained processing facility configured to efficiently convert high water-content slurries into its constituent solid and liquid fractions and subsequently generating and collecting clean water and concentrating desirable constituents with a boiling point lower than water.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: October 13, 2020
    Assignee: SEDRON TECHNOLOGIES, LLC
    Inventors: Peter William Janicki, Sara Amber Van Tassel, John Edward Weller, Stanley James Janicki, Warren Lewis Heartwood, Keith Boyd Fackler, II, Alex James Gross, Tyler Everett Hamke, Austin George Law, Eric Christopher McBride, Ann Kate Nowinski, Liam Joseph Potocsnak, James O'Keefe Armstrong
  • Publication number: 20200299969
    Abstract: A rooftop equipment attachment system includes a rooftop having a roof deck, an insulation layer positioned atop the roof deck, a plurality of metallic roof plates that secure the insulation layer to the roof deck, and a roofing membrane secured atop the insulation layer. The roofing membrane covers the plurality of metallic roof plates. The system includes a frame for supporting rooftop equipment. The frame includes a plurality of mounting supports that are positionable atop the rooftop at positions that are above at least a portion of the plurality of metallic roof plates. The plurality of mounting supports are configured to support the frame and any rooftop equipment mounted thereon. Each of the plurality of mounting supports includes a magnetic element that is configured to secure a particular one of the plurality of mounting supports with a particular one of the plurality of metallic roof plates.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 24, 2020
    Inventors: Christopher McBride, Zebonie Sukle
  • Publication number: 20200191317
    Abstract: An insulation product for a pipe-in-pipe pipeline having a clamshell assembly formed of a lightweight, semi-rigid material forming an annular cylinder when closed around a pipe and configured to fill an internal space of a pipe-in-pipe pipeline system. The annular cylinder is split into multiple sections, each section having an internal void filled with insulating material, such as aerogel. The multiple sections are connected by flexible portions or hinges. The aerogel insulation is contained within a section of the annular cylinder. The clamshell assembly is quickly and simply installed to a pipeline and accepts a wide variety of insulation types and forms to reduce production time and expense.
    Type: Application
    Filed: December 17, 2018
    Publication date: June 18, 2020
    Inventors: Christopher McBride, Christopher James Griffin, Jason Koravos
  • Publication number: 20190337965
    Abstract: The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1? and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.
    Type: Application
    Filed: July 16, 2019
    Publication date: November 7, 2019
    Applicant: Genentech, Inc.
    Inventors: Jeffrey A. STAFFORD, James M. VEAL, Lynnie Lin TRZOSS, Christopher MCBRIDE
  • Patent number: 10328089
    Abstract: Disclosed are compounds of Formula 1, stereoisomers thereof and pharmaceutically acceptable salts of the compounds and stereoisomers, wherein R1 and R2 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: June 25, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zacharia Cheruvallath, John David Lawson, Christopher McBride
  • Publication number: 20180050051
    Abstract: Disclosed are compounds of Formula 1, stereoisomers thereof and pharmaceutically acceptable salts of the compounds and stereoisomers, wherein R1 and R2 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Application
    Filed: October 27, 2017
    Publication date: February 22, 2018
    Inventors: Zacharia Cheruvallath, John David Lawson, Christopher McBride
  • Patent number: 9827255
    Abstract: Disclosed are compounds of Formula 1, stereoisomers thereof and pharmaceutically acceptable salts of the compounds and stereoisomers, wherein R1 and R2 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: November 28, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zacharia Cheruvallath, John David Lawson, Christopher McBride
  • Patent number: 9475816
    Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein L, R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: October 25, 2016
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zacharia Cheruvallath, Mallareddy Komandla, John David Lawson, Christopher McBride, Mingnam Tang
  • Patent number: 9434743
    Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, and R6 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: September 6, 2016
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zacharia Cheruvallath, Philip Erickson, Jun Feng, Mallareddy Komandla, John David Lawson, Christopher McBride, Joanne Miura, Sean Murphy, Mingnam Tang, Huong-Thu Ton-Nu
  • Publication number: 20160175332
    Abstract: Disclosed are compounds of Formula 1, stereoisomers thereof and pharmaceutically acceptable salts of the compounds and stereoisomers, wherein R1 and R2 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 23, 2016
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Zacharia Cheruvallath, John David Lawson, Christopher McBride
  • Publication number: 20150225405
    Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein L, R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Application
    Filed: September 6, 2013
    Publication date: August 13, 2015
    Inventors: Zacharia Cheruvallath, Mallareddy Komandla, John David Lawson, Christopher McBride, Mingnam Tang
  • Publication number: 20150005232
    Abstract: Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, and R6 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
    Type: Application
    Filed: February 28, 2013
    Publication date: January 1, 2015
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Zacharia Cheruvallath, Philip Erickson, Jun Feng, Mallareddy Komandla, John David Lawson, Christopher McBride, Joanne Miura, Sean Murphy, Mingnam Tang, Huong-Thu Ton-Nu
  • Patent number: D770271
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: November 1, 2016
    Assignee: D&W Fine Pack
    Inventor: Christopher McBride